-
Signature
-
/s/ Thomas J. Wilson
-
Issuer symbol
-
ALL
-
Transactions as of
-
20 Oct 2025
-
Transactions value $
-
-$3,260,883
-
Form type
-
4
-
Filing time
-
22 Oct 2025, 16:24:43 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| WILSON THOMAS J |
Chairman, President & CEO, Director |
C/O THE ALLSTATE CORPORATION, 3100 SANDERS ROAD, NORTHBROOK |
/s/ Thomas J. Wilson |
21 Oct 2025 |
0001190466 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ALL |
Common Stock |
Sale |
-$2.14M |
-11K |
-5.2% |
$193.69 |
201K |
20 Oct 2025 |
Direct |
F1, F2 |
| transaction |
ALL |
Common Stock |
Sale |
-$872K |
-4.49K |
-2.23% |
$194.36 |
197K |
20 Oct 2025 |
Direct |
F2, F3 |
| transaction |
ALL |
Common Stock |
Sale |
-$212K |
-1.09K |
-0.55% |
$195.50 |
195K |
20 Oct 2025 |
Direct |
F2, F4 |
| transaction |
ALL |
Common Stock |
Sale |
-$39.5K |
-201 |
-0.1% |
$196.50 |
195K |
20 Oct 2025 |
Direct |
F2, F5 |
| holding |
ALL |
Common Stock |
|
|
|
|
|
111K |
20 Oct 2025 |
By 2023-B GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
65.3K |
20 Oct 2025 |
By 2024-C GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
69.8K |
20 Oct 2025 |
By 2025-A GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
7.65K |
20 Oct 2025 |
By 401(k) Plan |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
274K |
20 Oct 2025 |
By 2020 GRAT Remainder Trust |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
258K |
20 Oct 2025 |
Remainder GRAT |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: